Scout | NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

This grant opportunity aims to quickly turn innovative lab research into treatments for eye diseases or disorders. Teams of scientists and clinicians are expected to produce preclinical data to develop treatments, like drugs or medical devices, that could lead to applications for FDA approval or clinical trials. Applicants should outline clear milestones for developing these therapies or devic…

Source

Agency: National Institutes of Health

Sub-agency: National Eye Institute

Dates

Opportunity Released: January 7, 2025

Keywords

visual system diseases

therapeutic development

preclinical data

multidisciplinary research

biological interventions

pharmacological resources

medical devices

clinical trials

FDA application

milestone-driven research

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers